Preparation and performance evaluation of saquinavir laden cationic submicron emulsions

Drug Delivery

Volumn 16, Issue 1, 2009, Pages 37-44

  Jain, V ^a   Prasad, V ^a   Jadhav, P ^a   Mishra, P R ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Absorption

Indexed keywords

CATION; CHITOSAN; LACTATE DEHYDROGENASE; OCTADECYLAMINE; PROTAMINE; SAQUINAVIR; AMINE; EXCIPIENT; PROTEINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; EMULSION; ENZYME RELEASE; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; IN VITRO STUDY; INTESTINE ABSORPTION; METABOLISM; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; SPRAGUE DAWLEY RAT; TOXICITY TESTING;

ADMINISTRATION, ORAL; AMINES; ANIMALS; CATIONS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; HIV PROTEASE INHIBITORS; INTESTINAL ABSORPTION; L-LACTATE DEHYDROGENASE; MALE; PARTICLE SIZE; PROTAMINES; RATS; RATS, SPRAGUE-DAWLEY; SAQUINAVIR; TOXICITY TESTS;

EID: 70349562924     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802481646     Document Type: Article

References (19)

1. Bouer A, Werther K, Catao-Dias JL, Nunes AL (1999). The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: In vitro studies using the rat everted intestinal sac. Fundam. Clin. Pharmacol. 13, 494-500.
2. Calvo P, Vila-Jato JL, Alonso MJ (1997). Evaluation of cationic polymer- coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153, 41-50. (Pubitemid 27283332)
3. Facklam MM, Burhenne J, Ding R, Fricker R, Mikus G, Zaman N T, Tam YK, Tawfik S, Wiltshire H (2004). Factors responsible for the variability of Saquinavir absorption: Studies using an instrumented dog model. Pharm. Res. 21, 436-442.
4. Frappier S, Breilh D, Diarte E, Ba B, Ducint, D, Pellegrin JL, Saux MC (1998). Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 714, 384-389.
5. Gershanik T, Benzeno S, Benita S (1998). Interaction of a self emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm. Res. 15, 863-869.
6. Illum L, Farraj NF, Davis SS (1994). Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11, 1186-1189.
7. Jumaa M Muller BW, (1998a). The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm. 163, 81-89.
8. Jumaa M, Muller BW (1998b). The stabilization of parenteral fat emulsion using non-ionic ABA copolymer surfactant. Int. J. Pharm. 174, 29-37.
9. Jumaa M, Muller BW, (1999). Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process. Int. J. Pharm. 183, 175-184.
10. Kim RB, Fromm, MF, Wandel, C, Leake B, Wood, AJJ, Roden DM, Wilkinson GR (1998). The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101, 289-294.
11. Kotze AF, Lueen HL, De BJ, Boer AG, Verhoef JC, Junginger, H (1998). Comparison of the effect of different chitosan salts and N-trimethylchitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Contr. Rel. 51:35-46.
12. Kozte AF, Thanou MM, Lueßen HL, Boer AG, Verhoef JC, Junginger HE (1999). Effect of degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). Eur. J. Pharm. Biopharm. 47, 269-274.
13. Myers RA, Stella VJ (1992). Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int. J. Pharm. 78, 217-220.
14. Rubinstein A, Pathak YV, Kleinstein J, Reches A, Benita S (1991). In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsion. J. Pharm. Sci. 80, 643-647.
15. Schipper NGM, Olsson S, Hoogstraate JA, Boer AG, Varum KM, Artursson P (1997). Chitosan as absorption enhancers for poorly absorbable drugs: mechanism of absorption enhancement. Pharm. Res. 14, 923-929.
16. Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y (2006). Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine. J. Liposome Res. 16, 127-141.
17. Uno T, Kazui T, Suzuki Y, Hashimoto H, Suzuki K, Muhammad, BA, (1999). Pharmacokinetic advantages of a newly developed tacrolimus oil-in-water-type emulsion via the enteral route. Lipids 34, 249-254.
18. Venkateswarlu V, Manjunath M, (2004). Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Contr. Rel. 95, 627-638.
19. Yang SC, Benita S, (2000). Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Dev. Res. 50, 476-486.